RobustcfDNAandCTCcollectionforliquidbiopsyandNIPT
LBgardBloodTubesaredirect-drawbloodcollectiontubespre-filledwithaproprietary,reagentthatstABIlizescellsandcell-freeDNA(cfDNA)inwholeblood,preservingBIOLOGicalanalytesfordownstreamapplications.LBgardBloodTubesalsopreventthereleaseofcellularcomponentsthatcaninterferewithanalysis,suchascellulargenomicDNAandproductsfromhemolysis. SamplescollectedinLBgardBloodTubes,whenstoredat4°C–37°C,arestabilizedfordownstreamcirculatingtumorDNAandcell-freeDNAapplicationsforupto14days.
Properties | LBgard | CompetitorS | CompetitorP |
---|---|---|---|
PlasmaVolumeRecovery | |||
ShippingRobustness | |||
cfDNAPreservation | |||
NogDNAcontamination | |||
PBMC/CTCPreservation | |||
CellSurfaceProteins | |||
ProtocolLength | Short | Long | Shortest |
EaseofPhlebotomy | Easy | Difficult | Easy |
SplatterPrevention | Excellent | Poor | Poor |
RiskofTubeBreakage | Low | High | Low |
MinimalLot-to-LotVariability | N/D |
Selecttherightcollectiondeviceandpre-analyticvariabilitycanbereduced.Thewrongchoicecancauseinterference,delayproductlaunch,andevennecessitatere-validationofdevelopedtests.
Thisevaluationprotocolwillhelpyoudesignanexperimentthataccountsforreal-worldenvironmentalstressesandassesstheoverallrobustnessofperformance.Akeyerrorinselectingthecorrectdeviceisfailingtoincludeshippingtimeandtemperaturestresses.
DOWNLOADEVALUATIONPROTOCOLHERE
SaveSave
SaveSave
SaveSave
Clicktoexpandeachcategory&subcategory.
Biomatrica在每种疾病中都有一个潜伏期,在这个阶段,如果我们能够检测出该疾病,我们可以在致死性疾病之前进行治疗。